Inhibition of cell proliferation by an anti-EGFR aptamer - Wikidata - thesis-toulmin - TriplyDB

Inhibition of cell proliferation by an anti-EGFR aptamer

Inhibition of cell proliferation by an anti-EGFR aptamer

http://www.wikidata.org/entity/Q28743866

about

Aptamers: A promising chemical antibody for cancer therapy Generation of Aptamers with an Expanded Chemical Repertoire Nucleic acid aptamers: research tools in disease diagnostics and therapeutics From ugly duckling to swan: unexpected identification from cell-SELEX of an anti-Annexin A2 aptamer targeting tumors A neutralizing RNA aptamer against EGFR causes selective apoptotic cell death DNA-aptamer targeting vimentin for tumor therapy in vivo.Cell-SELEX Identifies a "Sticky" RNA Aptamer Sequence.Selective uptake and imaging of aptamer- and antibody-conjugated hollow nanospheres targeted to epidermal growth factor receptors overexpressed in head and neck cancer Multifunctional aptamer-miRNA conjugates for targeted cancer therapy.Biochemical and structural features of extracellular vesicle-binding RNA aptamers.Selection of Nucleic Acid Aptamers Targeting Tumor Cell-Surface Protein Biomarkers Nanoformulated cell-penetrating survivin mutant and its dual actions.MAVTgsa: an R package for gene set (enrichment) analysis.A general RNA motif for cellular transfection.Mechanisms of Myofascial Pain Proliferation and migration of tumor cells in tapered channels.Aptamer to ErbB-2/HER2 enhances degradation of the target and inhibits tumorigenic growth.Development of an efficient targeted cell-SELEX procedure for DNA aptamer reagents.Highly stable aptamers selected from a 2'-fully modified fGmH RNA library for targeting biomaterials.DNA aptamers against exon v10 of CD44 inhibit breast cancer cell migration.Molecular Recognition of Human Liver Cancer Cells Using DNA Aptamers Generated via Cell-SELEX.Selective Targeting to Glioma with Nucleic Acid Aptamers Cell-penetrating RNAs: new keys to the castle.Electrical detection of cancer biomarker using aptamers with nanogap break-junctions.Intracellular Expression of PAI-1 Specific Aptamers Alters Breast Cancer Cell Migration, Invasion and Angiogenesis.Aptamer-mediated delivery of chemotherapy to pancreatic cancer cells Current progress of RNA aptamer-based therapeutics.Ets1 identified as a novel molecular target of RNA aptamer selected against metastatic cells for targeted delivery of nano-formulation.Identification and characterization of an agonistic aptamer against the T cell costimulatory receptor, OX40.Identification of an aptamer through whole cell-SELEX for targeting high metastatic liver cancers.Inhibition of receptor signaling and of glioblastoma-derived tumor growth by a novel PDGFRβ aptamer.Recombinant IgE antibody engineering to target EGFR.The application of aptamers in cancer research: an up-to-date review.Application of aptamers for targeted therapeutics.Translational Approaches towards Cancer Gene Therapy: Hurdles and Hopes.Aptamers: problems, solutions and prospects.Oligonucleotide aptamers: new tools for targeted cancer therapy.Nucleic acid aptamers in cancer research, diagnosis and therapy.Aptamer-mediated delivery of splice-switching oligonucleotides to the nuclei of cancer cells.Trends in the Design and Development of Specific Aptamers Against Peptides and Proteins.

P2860

Q26766832-D2B5E42A-ACF6-42EA-A81D-CD3C096293E6 Q26782794-239C25B9-E333-404D-A4A4-31A58E2A2495 Q26824321-58C324DC-3BD5-43E4-9C52-8DB48164E790 Q27326068-EFF2B07A-4028-45D6-9FB9-C212DC6B42FF Q28740749-6F09CC99-78C9-40D1-9FB2-237104D1BA38 Q30415521-F63A0D4D-C8E3-4FA7-BFBC-6DBE151313C2 Q30836916-C0D946F4-3ACA-4096-9EC9-3ABFC4EBF06F Q33716048-5AF1C330-3CB3-4253-BE8B-40C533904F8A Q33724277-8351E1CB-CBBC-46A1-A975-C06596A0D566 Q33742127-649996DB-A01D-4EE5-A6F9-202EF335937D Q33832781-42447A5D-0560-4B20-A1B4-2C4D33DA2DD5 Q33904982-1EA3AD70-5381-4292-AF64-3000C2B2F82C Q33914502-0F8C4855-77D0-4F41-862B-C1EBA0F95A56 Q34123063-6349BFAB-F9A1-44A2-AD94-A88927034E69 Q34457446-8BAECEEC-0DFD-42E5-92EA-5A7F378292C6 Q34458892-27492CF4-846D-46F8-BC22-9EEB88233B6A Q34695253-1937051B-BABC-4D84-BA9E-10E90AFC8E06 Q34964507-319DF025-8A86-4478-BD34-651DA091A04F Q34979624-F285E9F5-9A02-49E8-A2E2-B09C013DA0B1 Q35106226-7D2C4FFC-11F2-4334-8659-45E1BD570647 Q35621766-4BAABE98-84FA-4863-A10D-F5F22DC8333A Q35740074-3E64A0AB-432A-43FB-B1D7-D94BB50A180F Q35749991-BFF69D1F-500E-47E3-822E-7370F936B7BB Q36116287-F4F75540-BAA6-4FD1-A385-E224FE07FD16 Q36166157-815A05A6-7CD3-42A4-A7F1-470A0AD3C753 Q36298003-7E3060F5-D2B6-490D-B8D2-9947873EB722 Q36365202-24270C38-8A2A-4826-940E-19ADECB45F42 Q36394059-00451BBF-010B-4B76-852D-7CCE6B622609 Q36603032-7BC549FE-779D-4F59-9654-35996A1FF6BE Q36946778-5CBC7965-3DA4-49AB-9F72-149202C00236 Q37696048-9D4C2BB1-9433-4D81-8E78-B8BCA1FD80F6 Q38016758-01F153C9-8C7D-44B6-A62F-26A85DC5A5D8 Q38087391-1247D92D-75E9-4250-9894-2003E733C1E9 Q38096870-62A60EB2-A4B4-430E-9C1F-B5FAB1B50DD4 Q38107203-CF862C37-085A-4811-A2E5-857FB7138FC0 Q38181121-52612C1D-01EA-4A58-AF1C-4B3858A40664 Q38237132-FF705DCE-4C4A-40D9-89EE-CDCF3D7737B3 Q38308357-29E514A0-422E-4BA9-8F1C-9432B41A3329 Q38324414-95F52733-CC84-4ECE-990F-8D16D45E8957 Q38777639-991F72FF-9108-420C-B302-1601044097C3

P2860

Inhibition of cell proliferation by an anti-EGFR aptamer

http://www.wikidata.org/entity/Q28743866

description

2011 nî lūn-bûn

@nan

2011 թուականին հրատարակուած գիտական յօդուած

@hyw

2011 թվականին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Inhibition of cell proliferation by an anti-EGFR aptamer

@ast

Inhibition of cell proliferation by an anti-EGFR aptamer

@en

Inhibition of cell proliferation by an anti-EGFR aptamer

@nl

type

label

Inhibition of cell proliferation by an anti-EGFR aptamer

@ast

Inhibition of cell proliferation by an anti-EGFR aptamer

@en

Inhibition of cell proliferation by an anti-EGFR aptamer

@nl

prefLabel

Inhibition of cell proliferation by an anti-EGFR aptamer

@ast

Inhibition of cell proliferation by an anti-EGFR aptamer

@en

Inhibition of cell proliferation by an anti-EGFR aptamer

@nl

P1433

Q28743866-88F8BB82-4E42-46EF-9BDF-1DF28D5EF326

P1476

Q28743866-F5D11EFB-84C6-465B-9502-8A31F76D3DB3

P2093

Q28743866-2D5A8016-672F-4325-B781-FCFCF5853FEF

Q28743866-77325337-AAD0-4606-8208-3E0966675D68

Q28743866-B686BA48-CA23-4644-8756-7AACB66300B2

Q28743866-BFF665AF-A15D-4218-B8CB-4579D161F3FE

P2860

Q28743866-01C36731-A9E1-4A01-83C8-D40CFAA59E9E

Q28743866-11DC630F-BBA5-43EB-9E44-A2D220AC5C1E

Q28743866-192E7BD2-E6B1-4BAA-B34E-FFABA4AC7DC4

Q28743866-21AF64BB-C424-446D-B025-3C456C5DFD58

Q28743866-237043D7-2BF9-4396-B4E5-70AE41D25D22

Q28743866-24BCB94E-6591-4C21-8C0C-B4655E295265

Q28743866-277733C1-0F7E-4D52-859A-E78AE61C19DA

Q28743866-28533B1D-6420-41BC-AEA9-6FF492C52945

Q28743866-29EC44A4-C054-487E-B83D-6AD1E138DEA9

Q28743866-2D688FA4-A812-484E-91BF-DBECE62519E7

P304

Q28743866-76D52979-23A6-426B-85F5-04141FD75F86

P31

Q28743866-59B1D456-9B07-47D9-85E5-125ABE65BB3E

P3181

Q28743866-48859701-BDA7-49C4-8760-826DFC335EAC

P356

Q28743866-8EA90A41-4585-4326-A40B-ACBE100D6050

P407

Q28743866-27A36B5B-277E-4332-9E5E-8C4F8C2856E6

P433

Q28743866-7340D9AB-2958-4AB0-A200-6FE5495C47FD

P478

Q28743866-C7D8AFB0-37AF-4167-85A6-6E7648BFB0CA

P577

Q28743866-527BD1F7-80C7-4089-9F22-DBC212A555CF

P5875

Q28743866-1ECA973C-15FE-4DA3-A80E-30BB6F3CC7E7

P698

Q28743866-944DFA28-47D3-440C-B97A-39CA6D0B3168

P932

Q28743866-7B788698-165F-4760-B65E-B26E6BA066E6

P3181

P356

JOURNAL.PONE.0020299

P1433

P1476

Inhibition of cell proliferation by an anti-EGFR aptamer

@en

P2093

Andrew D Ellington

http://www.w3.org/2001/XMLSchema#string

Hong Hanh Nguyen

http://www.w3.org/2001/XMLSchema#string

Michelle Byrom

http://www.w3.org/2001/XMLSchema#string

Na Li

http://www.w3.org/2001/XMLSchema#string

P2860

Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains

Cetuximab/C225-induced intracellular trafficking of epidermal growth factor receptor

Neutralizing aptamers from whole-cell SELEX inhibit the RET receptor tyrosine kinase

EGFR antagonists in cancer treatment

Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen.

SELEX--a (r)evolutionary method to generate high-affinity nucleic acid ligands.

Aptamer-targeted cell-specific RNA interference

Aptamers as therapeutic and diagnostic agents.

The EGF receptor family as targets for cancer therapy.

Active and inactive conformations of the epidermal growth factor receptor.

P304

e20299

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2939936

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PONE.0020299

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2011-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51233079

http://www.w3.org/2001/XMLSchema#string

P698

21687663

http://www.w3.org/2001/XMLSchema#string

P932

3110755

http://www.w3.org/2001/XMLSchema#string